Details:

Personal Author:
Mack, Karin A. ; Frazier, Linda ; Terplan, Mishka ; Iskander, John K. ; Thorpe, Phoebe ; ... More +
Mack, Karin A. ; Frazier, Linda ; Terplan, Mishka ; Iskander, John K. ; Thorpe, Phoebe ; Laird, Susan Less -
Corporate Authors:
Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for Injury Prevention and Control (U.S.). Division of Analysis Research and Practice Integration.
Centers for Disease Control and Prevention (U.S.). Office of the Associate Director for Communication. ; National Center for Injury Prevention and Control (U.S.). Division of Analysis Research and Practice Integration. Less -
Description:
Tuesday, January 17, 2017 at 1 p.m. EST

Deaths from drug overdoses are the number one cause of injury death in the U.S. Most of these deaths are related to the misuse of prescription opioids and heroin. While men were more likely than women to die of opioid overdose, the number of overdose deaths from opioids among women has increased substantially. Since 1999, women’s deaths have quadrupled from prescription opioid overdose.

Consider the following:

• Nearly 48,000 women died of prescription opioid overdose between 1999 and 2010.

• For every woman who dies of a prescription opioid overdose, over 30 of them go the emergency department for opioid misuse or abuse.

Women’s biological differences may influence susceptibility to substance abuse, which could have implications for prevention and treatment. In order to identify and treat women most at risk, health care providers must be able to recognize and consider these differences.

Join us as we discuss how health care providers, researchers, and the public health community can best address the complexities of opioid use disorder among women. Speakers will give an overview of the federal response to the disorder, along with approaches to care and prevention of substance use.

Presented by: Karin A. Mack, PhD, Associate Director for Science, Division of Analysis Research and Practice Integration, National Center for Injury Prevention and Control, CDC [“Overview of Opioid Use Disorder in Women and the Federal Response”]; Linda Frazier, RN, MCHES, CADC, Director, Addictions Initiatives, Chair, APHA ATOD Section, Advocates for Human Potential, Inc.

[“Comprehensive Approaches to Care of Women with Substance Use Disorders”]; Mishka Terplan, MD, MPH, FACOG, FASAM, Professor, Department of Obstetrics and Gynecology, Professor, Department of Psychiatry, Associate Director, Addiction Medicine, Virginia Commonwealth University [“Prevention of Substance Use through Integration into Healthcare”].

Facilitated by: John Iskander, MD, MPH, Scientific Director, Public Health Grand Rounds; Phoebe Thorpe, MD, MPH, Deputy Scientific Director, Public Health Grand Rounds; Susan Laird, MSN, RN, Communications Director, Public Health Grand Rounds.


Subject:
[+]
Analgesics, Opioid
Opioid-Related Disorders
Pain Management
Women
Women's Health

Series:
Public Health grand rounds ; 2017 January 17
Document Type:
Presentation
Collection(s):
Stephen B. Thacker CDC Library collection
Main Document Checksum:
[+]
urn:sha256:4f8b0b91e8b128aa837586716b5bc477706df605e1f1dc387f7e7a00284b704e
File Type:

Supporting Files

• No Additional Files

More +